196 related articles for article (PubMed ID: 34546498)
21. Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases.
Faruqi S; Ruschin M; Soliman H; Myrehaug S; Zeng KL; Husain Z; Atenafu E; Tseng CL; Das S; Perry J; Maralani P; Heyn C; Mainprize T; Sahgal A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):772-779. PubMed ID: 31928848
[TBL] [Abstract][Full Text] [Related]
22. Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases.
Nguyen TK; Sahgal A; Detsky J; Atenafu EG; Myrehaug S; Tseng CL; Husain Z; Heyn C; Maralani P; Ruschin M; Perry J; Soliman H
Neuro Oncol; 2020 Jan; 22(1):84-93. PubMed ID: 31412120
[TBL] [Abstract][Full Text] [Related]
23. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of 30 Gy/5 Fr Hypofractionated Stereotactic Radiation Therapy for Small Brain Metastases (≤2 cm).
Kawai Y; Aramaki S; Ishihara T; Suzuki K; Okawa T; Sato E; Ota N; Kosugi T; Amano M; Konishi K
Anticancer Res; 2023 Oct; 43(10):4543-4549. PubMed ID: 37772575
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy.
Broemme J; Abu-Isa J; Kottke R; Beck J; Wiest R; Malthaner M; Schmidhalter D; Raabe A; Aebersold DM; Pica A
Strahlenther Onkol; 2013 Sep; 189(9):765-70. PubMed ID: 23934329
[TBL] [Abstract][Full Text] [Related]
27. [Risk of radionecrosis after hypofractionated stereotactic radiotherapy targeting the postoperative resection cavity of brain metastases].
Keller A; Doré M; Antoni D; Menoux I; Thillays F; Clavier JB; Delpon G; Jarnet D; Bourrier C; Lefebvre F; Chibbaro S; Darié I; Proust F; Noël G
Cancer Radiother; 2017 Aug; 21(5):377-388. PubMed ID: 28551018
[TBL] [Abstract][Full Text] [Related]
28. Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.
Garimall S; Shanker M; Johns E; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
J Neurooncol; 2020 Jan; 146(2):357-362. PubMed ID: 31907796
[TBL] [Abstract][Full Text] [Related]
29. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure.
Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
Cancer Radiother; 2020 Jul; 24(4):298-305. PubMed ID: 32173270
[TBL] [Abstract][Full Text] [Related]
30. Retrospective analysis of hypofractionated stereotactic radiotherapy for tumors larger than 2 cm.
Koide Y; Tomita N; Adachi S; Tanaka H; Tachibana H; Kodaira T
Nagoya J Med Sci; 2019 Aug; 81(3):397-406. PubMed ID: 31579330
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach.
Märtens B; Janssen S; Werner M; Frühauf J; Christiansen H; Bremer M; Steinmann D
BMC Cancer; 2012 Oct; 12():497. PubMed ID: 23098039
[TBL] [Abstract][Full Text] [Related]
32. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.
Minniti G; Clarke E; Lanzetta G; Osti MF; Trasimeni G; Bozzao A; Romano A; Enrici RM
Radiat Oncol; 2011 May; 6():48. PubMed ID: 21575163
[TBL] [Abstract][Full Text] [Related]
34. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.
Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
Radiother Oncol; 2006 Oct; 81(1):18-24. PubMed ID: 16978720
[TBL] [Abstract][Full Text] [Related]
36. Treatment of brain oligometastases with hypofractionated stereotactic radiotherapy utilising volumetric modulated arc therapy.
Croker J; Chua B; Bernard A; Allon M; Foote M
Clin Exp Metastasis; 2016 Feb; 33(2):125-32. PubMed ID: 26482476
[TBL] [Abstract][Full Text] [Related]
37. Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis.
Alfredo C; Carolin S; Güliz A; Anne K; Antonio P; Alberto C; Stefano P; Antonino G; Harun B; Markus K; Franziska M; Phuong N; Franziska L; Peter V; Volker B; David K
Radiat Oncol; 2019 Nov; 14(1):201. PubMed ID: 31718650
[TBL] [Abstract][Full Text] [Related]
38. Hypofractionated adjuvant surgical cavity radiotherapy following resection of limited brain metastasis.
Wijetunga A; Jayamanne D; Cook R; Parkinson J; Little N; Curtis J; Brown C; Back M
J Clin Neurosci; 2020 Dec; 82(Pt A):155-161. PubMed ID: 33317725
[TBL] [Abstract][Full Text] [Related]
39. Brain metastases resection cavity radio-surgery based on T2-weighted MRI: technique assessment.
Teyateeti A; Brown PD; Mahajan A; Laack NN; Pollock BE
J Neurooncol; 2020 May; 148(1):89-95. PubMed ID: 32303974
[TBL] [Abstract][Full Text] [Related]
40. [Hypofractionated stereotactic radiotherapy for brain metastases].
Schlienger M; Nataf F; Huguet F; Pene F; Foulquier JN; Orthuon A; Roux FX; Touboul E
Cancer Radiother; 2010 Apr; 14(2):119-27. PubMed ID: 20004125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
